We are live on ! Find out more
THC icon

Tenet Healthcare

405 hedge funds and large institutions have $9.03B invested in Tenet Healthcare in 2022 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 131 increasing their positions, 138 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 41

8% more funds holding

Funds holding: 374405 (+31)

8% more capital invested

Capital invested by funds: $8.36B → $9.03B (+$672M)

7% more funds holding in top 10

Funds holding in top 10: 1516 (+1)

0.7% more ownership

Funds ownership: 95.71%96.41% (+0.7%)

5% less repeat investments, than reductions

Existing positions increased: 131 | Existing positions reduced: 138

18% less call options, than puts

Call options by funds: $143M | Put options by funds: $175M

Holders
405
Holders Change
+31
Holders Change %
+8.29%
% of All Funds
6.39%
Holding in Top 10
16
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+6.67%
% of All Funds
0.25%
New
76
Increased
131
Reduced
138
Closed
41
Calls
$143M
Puts
$175M
Net Calls
-$32.1M
Net Calls Change
-$80.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Allianz Asset Management
26
Allianz Asset Management
Germany
$70.3M +$1.85M +22,517 +3%
OCAM
27
Owl Creek Asset Management
New York
$69.7M +$11.7M +142,518 +21%
LBA
28
Letko, Brosseau & Associates
Quebec, Canada
$68.1M -$18.5M -225,235 -22%
Principal Financial Group
29
Principal Financial Group
Iowa
$67M +$33.9M +412,085 +112%
Deutsche Bank
30
Deutsche Bank
Germany
$64.1M -$5.62M -68,396 -8%
Barclays
31
Barclays
United Kingdom
$62M +$29.7M +361,582 +101%
CCM
32
Camber Capital Management
Massachusetts
$58M -$43.1M -525,000 -44%
O
33
OrbiMed
New York
$54M +$27.1M +329,300 +110%
JP Morgan Chase
34
JP Morgan Chase
New York
$50.5M -$20.2M -245,582 -29%
PHS
35
PFM Health Sciences
California
$46.8M +$1.53M +18,656 +4%
Ameriprise
36
Ameriprise
Minnesota
$41.6M +$3.03M +36,848 +8%
CGM
37
Capital Growth Management
Massachusetts
$39.5M -$1.64M -20,000 -4%
American Century Companies
38
American Century Companies
Missouri
$37.5M +$16.1M +195,876 +82%
Holocene Advisors
39
Holocene Advisors
New York
$36M +$34.4M +418,275 New
SC
40
Samlyn Capital
New York
$35.8M +$34.2M +416,795 New
FAM
41
Fred Alger Management
New York
$35.5M -$19.7M -240,327 -37%
SEI Investments
42
SEI Investments
Pennsylvania
$35.3M +$733K +8,923 +2%
RCM
43
Redwood Capital Management
New York
$34.3M
WCM
44
Wedge Capital Management
North Carolina
$34.2M -$5.1M -62,110 -14%
PI
45
Putnam Investments
Massachusetts
$33.9M -$860K -10,469 -3%
JCM
46
Junto Capital Management
New York
$30.1M +$28.8M +350,098 New
AllianceBernstein
47
AllianceBernstein
Tennessee
$27.8M -$1.53M -18,599 -5%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$27.1M -$202K -2,455 -0.8%
UBS Group
49
UBS Group
Switzerland
$27M +$5.13M +62,467 +25%
Point72 Asset Management
50
Point72 Asset Management
Connecticut
$26.8M +$17.4M +211,337 +210%

THC Hedge Fund Activity: Q1 2022 in Review

405 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tenet Healthcare (THC) for Q1 2022, worth a combined $9.03B — up 8% from $8.36B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new THC positions and 41 closed out — a net gain of 35 holders — while 131 added to existing stakes and 138 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $227M. The largest seller was Centerbridge Partners, exiting entirely with an estimated $182M sold.

  • 405 institutional investors held Tenet Healthcare (THC) as of Q1 2022, up from 374 in Q4 2021.
  • Funds reported $9.03B of Tenet Healthcare stock for Q1 2022, up 8% quarter-over-quarter.
  • 76 funds opened new Tenet Healthcare positions in Q1 2022 and 41 closed out, a net change of +35 holders.
  • The largest Tenet Healthcare buyer in Q1 2022 was Fidelity Investments, an estimated $227M added.
  • The largest Tenet Healthcare seller in Q1 2022 was Centerbridge Partners, an estimated $182M sold.

Based on aggregated 13F filings for Q1 2022.